Advertisement

Medical and Pharmaceutical Applications of Water Soluble Polymers

  • F. G. Hutchinson

Abstract

The use of hydrophilic polymers in medicine and pharmacy cannot be regarded as of recent origin, but it is only in the last 30 years or so that the potential of custom made synthetic products has begun to be realized. Applications of water soluble in biology, medicine and pharmacy are diverse, but can be classified under three general headings:-
  1. 1.

    Therapeutic — polymers having some intrinsic biological activity or effect and used as remedial agents;

     
  2. 2.

    Biomedical/prosthetic — polymers having minimal biological activity or good biocompatibility, used to replace or augment natural tissue;

     
  3. 3.

    Pharmaceutical — polymers having no biological activity, used in drug formulation/dosage design.

     

Keywords

Dosage Form Hydroxyethyl Methacrylate Maleic Anhydride Hydrophilic Polymer Water Soluble Polymer 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    ‘Anionic polymeric drugs’ (Ed, by L.G. Donaruma, R.M. Ottenbrite, and O. Vogl) 1980: New York. Wiley-Interscience.Google Scholar
  2. 2.
    R.N. Ottenbrite et al. in ‘Polymeric Drugs’ (Ed. by L.G. Donaruma and O. Vogl), 1978:New York. Academic Press, p.263.Google Scholar
  3. 3.
    D.S. Breslow, E.I. Edwards, and N.R. Newbury, Nature, 1973, 246, 160.CrossRefGoogle Scholar
  4. 4.
    M.C. Breinig et al., in Ref.1, p.211.Google Scholar
  5. 5.
    A.M. Kaplin, in Ref.1, p.227.Google Scholar
  6. 6.
    Y. Shamash and B. Alexander, Biochim.biophys. Acta, 1969, 194, 449.CrossRefGoogle Scholar
  7. 7.
    E.T. Felz and W. Regelson, Nature, 1962,196, 642.CrossRefGoogle Scholar
  8. 8.
    T.C. Merigan and M.S. Finkelstein, Virology, 1968, 35, 363.CrossRefGoogle Scholar
  9. 9.
    W. Regelson, S. Kuhar, M. Tunis, J. Fields, J. Johnson and E. Gluesenkamp, Nature, 1960, 186, 778.CrossRefGoogle Scholar
  10. 10.
    E. De Clercq and P. De Somer, Proc.Soc.exp.biol.med., 1969, 132, 699.Google Scholar
  11. 11.
    W.B. Ackart, R.L. Camp, W.L. Wheelwright and J. S. Byck, J.biomed. mater.Res., 1975, 9, 55.CrossRefGoogle Scholar
  12. 12.
    H.B. Levy in ‘Polymeric Drugs’ (Ed. by L.G. Donaruma and O. Vogl) 1978:New York. Academic Press. p.305.Google Scholar
  13. 13.
    ‘Martindale — The Extra Pharmacopoeia’. 1977:London. The Pharmaceutical Press, p.800.Google Scholar
  14. 14.
    V. Hofmann, M. Przybylski, H. Ringsdorf, and H. Ritter, Makromolek. Chem., 1976, 177, 1791.CrossRefGoogle Scholar
  15. 15.
    J. A. Brierly, L.G. Donaruma, S. Lockwood and R. Mercogliano, Amer. chem.Soc., Coatings and Plastics Preprints, 1980, 42, 432.Google Scholar
  16. 16.
    D.S. Breslow, Amer.chem.Soc, Polymer Preprints, 1980, 21, 1.Google Scholar
  17. 17.
    ‘Drugs Carriers in Biology and Medicine’ (Ed. by Gregory Gregoriadis). 1979:London. Academic Press.Google Scholar
  18. 18.
    P. Ferruti, Pharmacol.res.Comm., 1975, 7, 1.CrossRefGoogle Scholar
  19. 19.
    Population Reports (Sept.1976), Series H, No.5.Google Scholar
  20. 20.
    J. W. Cornforth, E.D. Morgan, K.T. Potts, and R.J. W. Rees, Tetrahedron, 1973, 29(11), 1659.CrossRefGoogle Scholar
  21. 21.
    H.A. Ravin, A.M. Seligman and J. Fine, New England J.med., 1952, 247, 921.CrossRefGoogle Scholar
  22. 22.
    J. L. Data and A.S. Nies, Ann.internat.med., 1972, 81, 500.CrossRefGoogle Scholar
  23. 23.
    G.G. Nahas, and A. Charra, Ger. Offentl. 2,020,453 (1970).Google Scholar
  24. G.G. Nahas, Presse med., 1970, 78, 19.Google Scholar
  25. 24.
    P. Neri, G. Antoni, F. Benvenuti, F. Cocola and G. Gazzei, J.med. chem., 1973, 16, 893.CrossRefGoogle Scholar
  26. 25.
    J. Kpoecek, L. Sprincl, and D. Lim, J.biomed.mater.Res., 1973, 7, 179.CrossRefGoogle Scholar
  27. 26.
    ‘Hydrogels for Medical and related Applications’, (Ed. by J. D. Andrade). American Chemical Society Symposium Series No.31. 1976:Washington. American Chemical Society.Google Scholar
  28. 27.
    D.G. Pedley, P.J. Skelly, and B.J. Tighe, Br.polymer J., 1980, 1, 99.Google Scholar
  29. 28.
    F.J. T. Fildes and F.G. Hutchinson, Ger. Offentl. 2,755,505 (1978).Google Scholar
  30. 29.
    T. Kunitomo, H. Kenjo, S. Nagaoka, T. Yoshioka and T. Tanzawa, U.S.P. 3,949,021 (1976).Google Scholar
  31. 30.
    B.J. Tighe, Br.polymer J., 1976, 8, 71.CrossRefGoogle Scholar
  32. 31.
    K.J. Muzkewicz, E.B. Crowell, jr., A.P. Hart, M. Schultz, C.G. Hill, jr., and S.L. Cooper, J.biomed.mater.Res., 1975, 9, 487.CrossRefGoogle Scholar
  33. 32.
    M. Tollar, M. Stol, and K. Kliment, J.biomed.mater.Res., 1969, 3, 305.CrossRefGoogle Scholar
  34. 33.
    M.P. Singh and A. Melrose, Biomed.eng., 1971, 6, 159.Google Scholar
  35. 34.
    B.E. Kent and A.D. Wilson, Br.dental J., 1973, 135, 322.CrossRefGoogle Scholar
  36. 35.
    E. Shotton, J. A. Hersey, P.E. Wray and W.C. Gunsel and J. L. Kanig in ‘The theory and practice of Industrial Pharmacy’ (Ed. by L. Lachman, H.A. Lieberman and J. L. Kania) 1976:Philadelphia. Lea & Febiger. Chapters 10–11.Google Scholar
  37. 36.
    L.A. Luzzi, J.pharm.Sci., 1970, 59, 1367.CrossRefGoogle Scholar
  38. 37.
    J. A. Bakan, and F.D. Sloan, Drug cosmetic Ind., 1972 (March), 110, 37.Google Scholar
  39. 38.
    J. A. Bakan, Polym.sci.technology, 1974, 8, 213.Google Scholar
  40. 39.
    ‘Microencapsulation: Processes and Applications’, (Ed. by J. E. Vandegaer). 1974:New York. Plenum Publishing.Google Scholar
  41. 40.
    ‘Microcapsules Processing and Technology’. A. Kondo. 1979:New York. Marcel Dekker Inc.Google Scholar
  42. 41.
    ’sustained and controlled Release Drug Delivery Systems’ (Ed. by J. R. Robinson). 1978:New York. Marcel Dekker Inc.Google Scholar
  43. 42.
    A. Zaffaroni, Chemtech, 1980(February),82.Google Scholar
  44. 43.
    A. Zaffaroni, American Chemical Society, Coatings and Plastics Preprints, 1980, 42, 441.Google Scholar
  45. 44.
    J. Heller, and P.Y. Trescony, J. Pharm.Sci., 1979, 68, 919.CrossRefGoogle Scholar
  46. 45.
    K.R. Sidman, A.D. Schwope, W.D. Steber, and S.E. Rudolph, NIDA Res. Monographs, 1981, 28, 214.Google Scholar
  47. 46.
    H.B. Hopfenberg, American Chemical Society Coatings and Plastics Preprints, 1976, 36(1),229.Google Scholar
  48. 47.
    ‘Biopharmaceutics and relevant Pharmacokinetics’ by J. G. Wagner. 1st Edition. 1971:Hamilton, Illinois. Drug Intelligence Publications.Google Scholar
  49. 48.
    V. Hon-Leung Lee, and J. R. Robinson, ‘Sustained and Controlled Release Drug Delivery Systems’ (Ed. by J. R. Robinson). 1978:New York. Marcel Dekker Inc. Chapter 3.Google Scholar
  50. 49.
    A.T. Florence, Pharmaceutical J. 1974, 13 July, p.36.Google Scholar
  51. 50.
    ‘Controlled Release of biologically active agents’ by A.C. Tanquary and R.E. Lacey. Advances in Experimental Medicine and biology, vol.47. 1974:New York. Plenum Publishing.Google Scholar
  52. 51.
    M. Donbrow and M. Friedman, J.pharm.pharmacol., 1975, 27, 647.CrossRefGoogle Scholar
  53. 52.
    R.A. Abrahams and S.H. Ronel, J.biomed.mater.Res., 1975, 2, 355.CrossRefGoogle Scholar
  54. 53.
    J. Drobnik, P. Spacek, O. Wichterle, J.biomed.mater.Res., 1974, 8, 45.CrossRefGoogle Scholar
  55. 54.
    J. M. Anderson, T. Koinis, T. Nelson, M. Horst and D.S. Lowe, American Chemical Society Polymer Preprints, 1975, 16, 376.Google Scholar
  56. 55.
    M.V. Sefton and E. Nishimura, J.pharm.Sci., 1980, 69, 208.CrossRefGoogle Scholar
  57. 56.
    V.J. Marmion and S. Yurdakul, Trans.ophthal.Soc.U.K., 1977, 97, 437.Google Scholar
  58. 57.
    R. Langer and J. Folkman, Nature, 1976, 263, 797.CrossRefGoogle Scholar
  59. 58.
    B.K. Davis, Experientia, 1972, 28, 34–8.Google Scholar
  60. 59.
    W.R. Good, Midland Macromol.Inst., ‘Polymeric Delivery Systems’ 1976, August, 5th.Internat.symp., p.139.Google Scholar
  61. 60.
    ‘Biomedical applications of immobilized enzymes and proteins’ Vol.1. (Ed. by T.M.S. Chang). 1977:New York Press.Google Scholar
  62. 61.
    E.I. Stupak and T.R. Bates, J.pharm.Sci., 1973, 62, 1806.CrossRefGoogle Scholar
  63. 62.
    E.I. Stupak and T.R. Bates, J.pharm.Sci.,1972, 61, 400.CrossRefGoogle Scholar
  64. 63.
    W.L. Chio and S. Reigelman, J.pharm.Sci., 1971, 60, 1376.CrossRefGoogle Scholar
  65. 64.
    B.A. Saggars and G.R. Stewart, J. Hyg., 1964, 62, 508.Google Scholar
  66. 65.
    J. Eliassaf, Europ.polymer J., 1966, 2, 269.CrossRefGoogle Scholar
  67. 66.
    D.H. Napper, Ind. eng. Chem., Prod.res.Devel., 1970, 9, 467.CrossRefGoogle Scholar
  68. 67.
    B.A. Haines, A.N. Martin, J.pharm.Sci., 1961, 50, 228,753,759.CrossRefGoogle Scholar
  69. 68.
    E.H. Hiestand, J.pharm.Sci.,1964., 53, 1.CrossRefGoogle Scholar
  70. 69.
    W.I. Higuchi and J. Misra, J.pharm.Sci., 1962, 51, 459.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1983

Authors and Affiliations

  • F. G. Hutchinson
    • 1
  1. 1.Pharmaceutical DivisionImperial Chemical Industries PLCMacclesfield, CheshireUK

Personalised recommendations